Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

Interleukin 4 Moderately Affects Competence of Pluripotent Stem Cells for Myogenic Conversion.

Świerczek-Lasek B, Neska J, Kominek A, Tolak Ł, Czajkowski T, Jańczyk-Ilach K, Stremińska W, Piwocka K, Ciemerych MA, Archacka K.

Int J Mol Sci. 2019 Aug 13;20(16). pii: E3932. doi: 10.3390/ijms20163932.

2.

Dynamics of cardiomyocyte transcriptome and chromatin landscape demarcates key events of heart development.

Pawlak M, Kedzierska KZ, Migdal M, Nahia KA, Ramilowski JA, Bugajski L, Hashimoto K, Marconi A, Piwocka K, Carninci P, Winata CL.

Genome Res. 2019 Mar;29(3):506-519. doi: 10.1101/gr.244491.118. Epub 2019 Feb 13.

3.

BRCA1 deficiency and synthetic lethality in leukemias; not only gene mutation matters.

Piwocka K, Podszywałow-Bartnicka P, Skorski T.

Postepy Biochem. 2018 Oct 15;64(2):141-147. doi: 10.18388/pb.2018_124. Review.

4.

Non-NAD-like PARP1 inhibitor enhanced synthetic lethal effect of NAD-like PARP inhibitors against BRCA1-deficient leukemia.

Nieborowska-Skorska M, Maifrede S, Ye M, Toma M, Hewlett E, Gordon J, Le BV, Sliwinski T, Zhao H, Piwocka K, Valent P, Tulin AV, Childers W, Skorski T.

Leuk Lymphoma. 2019 Apr;60(4):1098-1101. doi: 10.1080/10428194.2018.1520988. Epub 2018 Oct 2. No abstract available.

PMID:
30277116
5.

Characteristics of live parameters of the HS-5 human bone marrow stromal cell line cocultured with the leukemia cells in hypoxia, for the studies of leukemia-stroma cross-talk.

Podszywalow-Bartnicka P, Kominek A, Wolczyk M, Kolba MD, Swatler J, Piwocka K.

Cytometry A. 2018 Jul;93(9):929-940. doi: 10.1002/cyto.a.23580. Epub 2018 Sep 3.

6.

PARP1 inhibitor eliminated imatinib-refractory chronic myeloid leukemia cells in bone marrow microenvironment conditions.

Podszywalow-Bartnicka P, Maifrede S, Le BV, Nieborowska-Skorska M, Piwocka K, Skorski T.

Leuk Lymphoma. 2019 Jan;60(1):262-264. doi: 10.1080/10428194.2018.1471602. Epub 2018 Jun 22. No abstract available.

PMID:
29932782
7.

Tyrosine kinase inhibitor-induced defects in DNA repair sensitize FLT3(ITD)-positive leukemia cells to PARP1 inhibitors.

Maifrede S, Nieborowska-Skorska M, Sullivan-Reed K, Dasgupta Y, Podszywalow-Bartnicka P, Le BV, Solecka M, Lian Z, Belyaeva EA, Nersesyan A, Machnicki MM, Toma M, Chatain N, Rydzanicz M, Zhao H, Jelinek J, Piwocka K, Sliwinski T, Stoklosa T, Ploski R, Fischer T, Sykes SM, Koschmieder S, Bullinger L, Valent P, Wasik MA, Huang J, Skorski T.

Blood. 2018 Jul 5;132(1):67-77. doi: 10.1182/blood-2018-02-834895. Epub 2018 May 21.

8.

Transient MicroRNA Expression Enhances Myogenic Potential of Mouse Embryonic Stem Cells.

Bem J, Grabowska I, Daniszewski M, Zawada D, Czerwinska AM, Bugajski L, Piwocka K, Fogtman A, Ciemerych MA.

Stem Cells. 2018 May;36(5):655-670. doi: 10.1002/stem.2772. Epub 2018 Jan 22.

9.

MLL-AF9 leukemias are sensitive to PARP1 inhibitors combined with cytotoxic drugs.

Maifrede S, Martinez E, Nieborowska-Skorska M, Di Marcantonio D, Hulse M, Le BV, Zhao H, Piwocka K, Tempera I, Sykes SM, Skorski T.

Blood Adv. 2017 Aug 9;1(19):1467-1472. doi: 10.1182/bloodadvances.2017006247. eCollection 2017 Aug 22.

10.

Some chemotherapeutics-treated colon cancer cells display a specific phenotype being a combination of stem-like and senescent cell features.

Was H, Czarnecka J, Kominek A, Barszcz K, Bernas T, Piwocka K, Kaminska B.

Cancer Biol Ther. 2018 Jan 2;19(1):63-75. doi: 10.1080/15384047.2017.1385675. Epub 2017 Dec 22.

11.

New developments in cytometric phenotyping.

Asosingh K, Piwocka K, Schildberg FA.

Cytometry A. 2017 Oct;91(10):950-951. doi: 10.1002/cyto.a.23262. No abstract available.

12.

Ruxolitinib-induced defects in DNA repair cause sensitivity to PARP inhibitors in myeloproliferative neoplasms.

Nieborowska-Skorska M, Maifrede S, Dasgupta Y, Sullivan K, Flis S, Le BV, Solecka M, Belyaeva EA, Kubovcakova L, Nawrocki M, Kirschner M, Zhao H, Prchal JT, Piwocka K, Moliterno AR, Wasik M, Koschmieder S, Green TR, Skoda RC, Skorski T.

Blood. 2017 Dec 28;130(26):2848-2859. doi: 10.1182/blood-2017-05-784942. Epub 2017 Oct 17.

13.

[Exosomal microRNAs as a part of the cell-cell communication in cancer].

Wesołowska A, Piwocka K.

Postepy Biochem. 2017;63(2):110-118. Review. Polish.

14.

IGH/MYC Translocation Associates with BRCA2 Deficiency and Synthetic Lethality to PARP1 Inhibitors.

Maifrede S, Martin K, Podszywalow-Bartnicka P, Sullivan-Reed K, Langer SK, Nejati R, Dasgupta Y, Hulse M, Gritsyuk D, Nieborowska-Skorska M, Lupey-Green LN, Zhao H, Piwocka K, Wasik MA, Tempera I, Skorski T.

Mol Cancer Res. 2017 Aug;15(8):967-972. doi: 10.1158/1541-7786.MCR-16-0468. Epub 2017 Jun 20.

15.

Gene expression and mutation-guided synthetic lethality eradicates proliferating and quiescent leukemia cells.

Nieborowska-Skorska M, Sullivan K, Dasgupta Y, Podszywalow-Bartnicka P, Hoser G, Maifrede S, Martinez E, Di Marcantonio D, Bolton-Gillespie E, Cramer-Morales K, Lee J, Li M, Slupianek A, Gritsyuk D, Cerny-Reiterer S, Seferynska I, Stoklosa T, Bullinger L, Zhao H, Gorbunova V, Piwocka K, Valent P, Civin CI, Muschen M, Dick JE, Wang JC, Bhatia S, Bhatia R, Eppert K, Minden MD, Sykes SM, Skorski T.

J Clin Invest. 2017 Jun 1;127(6):2392-2406. doi: 10.1172/JCI90825. Epub 2017 May 8.

16.

Stress granules assembly affects detection of mRNA in living cells by the NanoFlares; an important aspect of the technology.

Wolczyk M, Podszywalow-Bartnicka P, Bugajski L, Piwocka K.

Biochim Biophys Acta Gen Subj. 2017 May;1861(5 Pt A):1024-1035. doi: 10.1016/j.bbagen.2017.02.010. Epub 2017 Feb 13.

PMID:
28196667
17.

Senescent peritoneal mesothelium creates a niche for ovarian cancer metastases.

Mikuła-Pietrasik J, Uruski P, Sosińska P, Maksin K, Piotrowska-Kempisty H, Kucińska M, Murias M, Szubert S, Woźniak A, Szpurek D, Sajdak S, Piwocka K, Tykarski A, Książek K.

Cell Death Dis. 2016 Dec 29;7(12):e2565. doi: 10.1038/cddis.2016.417.

18.

Bafilomycin A1 triggers proliferative potential of senescent cancer cells in vitro and in NOD/SCID mice.

Was H, Barszcz K, Czarnecka J, Kowalczyk A, Bernas T, Uzarowska E, Koza P, Klejman A, Piwocka K, Kaminska B, Sikora E.

Oncotarget. 2017 Feb 7;8(6):9303-9322. doi: 10.18632/oncotarget.14066.

19.

Increased phosphorylation of eIF2α in chronic myeloid leukemia cells stimulates secretion of matrix modifying enzymes.

Podszywalow-Bartnicka P, Cmoch A, Wolczyk M, Bugajski L, Tkaczyk M, Dadlez M, Nieborowska-Skorska M, Koromilas AE, Skorski T, Piwocka K.

Oncotarget. 2016 Nov 29;7(48):79706-79721. doi: 10.18632/oncotarget.12941.

20.

When polychromatic flow cytometry meets mitochondrial reactive oxygen species.

Piwocka K.

Cytometry A. 2016 Dec;89(12):1052-1053. doi: 10.1002/cyto.a.22980. Epub 2016 Sep 15. No abstract available.

21.

ESCRT proteins restrict constitutive NF-κB signaling by trafficking cytokine receptors.

Mamińska A, Bartosik A, Banach-Orłowska M, Pilecka I, Jastrzębski K, Zdżalik-Bielecka D, Castanon I, Poulain M, Neyen C, Wolińska-Nizioł L, Toruń A, Szymańska E, Kowalczyk A, Piwocka K, Simonsen A, Stenmark H, Fürthauer M, González-Gaitán M, Miaczynska M.

Sci Signal. 2016 Jan 19;9(411):ra8. doi: 10.1126/scisignal.aad0848.

PMID:
26787452
22.

High Potency of a Novel Resveratrol Derivative, 3,3',4,4'-Tetrahydroxy-trans-stilbene, against Ovarian Cancer Is Associated with an Oxidative Stress-Mediated Imbalance between DNA Damage Accumulation and Repair.

Mikuła-Pietrasik J, Sosińska P, Murias M, Wierzchowski M, Brewińska-Olchowik M, Piwocka K, Szpurek D, Książek K.

Oxid Med Cell Longev. 2015;2015:135691. doi: 10.1155/2015/135691. Epub 2015 Jul 1.

23.

Isolation of vascular endothelial cells from intact and injured murine brain cortex-technical issues and pitfalls in FACS analysis of the nervous tissue.

Wylot B, Konarzewska K, Bugajski L, Piwocka K, Zawadzka M.

Cytometry A. 2015 Oct;87(10):908-20. doi: 10.1002/cyto.a.22677. Epub 2015 Apr 17.

24.

Downregulation of BRCA1 protein in BCR-ABL1 leukemia cells depends on stress-triggered TIAR-mediated suppression of translation.

Podszywalow-Bartnicka P, Wolczyk M, Kusio-Kobialka M, Wolanin K, Skowronek K, Nieborowska-Skorska M, Dasgupta Y, Skorski T, Piwocka K.

Cell Cycle. 2014;13(23):3727-41. doi: 10.4161/15384101.2014.965013.

PMID:
25483082
25.

Low interleukin-8 level predicts the occurrence of the postpericardiotomy syndrome.

Jaworska-Wilczyńska M, Magalska A, Piwocka K, Szymański P, Kuśmierczyk M, Wąsik M, Hryniewiecki T.

PLoS One. 2014 Oct 21;9(10):e108822. doi: 10.1371/journal.pone.0108822. eCollection 2014.

26.

Stimulators of mineralization limit the invasive phenotype of human osteosarcoma cells by a mechanism involving impaired invadopodia formation.

Cmoch A, Podszywalow-Bartnicka P, Palczewska M, Piwocka K, Groves P, Pikula S.

PLoS One. 2014 Oct 14;9(10):e109938. doi: 10.1371/journal.pone.0109938. eCollection 2014.

27.

The role of nibrin in doxorubicin-induced apoptosis and cell senescence in Nijmegen Breakage Syndrome patients lymphocytes.

Alster O, Bielak-Zmijewska A, Mosieniak G, Moreno-Villanueva M, Dudka-Ruszkowska W, Wojtala A, Kusio-Kobiałka M, Korwek Z, Burkle A, Piwocka K, Siwicki JK, Sikora E.

PLoS One. 2014 Aug 13;9(8):e104964. doi: 10.1371/journal.pone.0104964. eCollection 2014.

28.

Synthetic resveratrol analogue, 3,3',4,4',5,5'-hexahydroxy-trans-stilbene, accelerates senescence in peritoneal mesothelium and promotes senescence-dependent growth of gastrointestinal cancers.

Mikuła-Pietrasik J, Sosińska P, Wierzchowski M, Piwocka K, Książek K.

Int J Mol Sci. 2013 Nov 14;14(11):22483-98. doi: 10.3390/ijms141122483.

29.

Bystander senescence in human peritoneal mesothelium and fibroblasts is related to thrombospondin-1-dependent activation of transforming growth factor-β1.

Mikuła-Pietrasik J, Sosińska P, Janus J, Rubiś B, Brewińska-Olchowik M, Piwocka K, Książek K.

Int J Biochem Cell Biol. 2013 Sep;45(9):2087-96. doi: 10.1016/j.biocel.2013.07.004. Epub 2013 Jul 17.

PMID:
23871936
30.

Inhibition of PCAF by anacardic acid derivative leads to apoptosis and breaks resistance to DNA damage in BCR-ABL-expressing cells.

Kusio-Kobialka M, Dudka-Ruszkowska W, Ghizzoni M, Dekker FJ, Piwocka K.

Anticancer Agents Med Chem. 2013 Jun;13(5):762-7.

PMID:
23157591
31.

The PERK-eIF2α phosphorylation arm is a pro-survival pathway of BCR-ABL signaling and confers resistance to imatinib treatment in chronic myeloid leukemia cells.

Kusio-Kobialka M, Podszywalow-Bartnicka P, Peidis P, Glodkowska-Mrowka E, Wolanin K, Leszak G, Seferynska I, Stoklosa T, Koromilas AE, Piwocka K.

Cell Cycle. 2012 Nov 1;11(21):4069-78. doi: 10.4161/cc.22387. Epub 2012 Oct 24.

32.

Increased acetylation of lysine 317/320 of p53 caused by BCR-ABL protects from cytoplasmic translocation of p53 and mitochondria-dependent apoptosis in response to DNA damage.

Kusio-Kobialka M, Wolanin K, Podszywalow-Bartnicka P, Sikora E, Skowronek K, McKenna SL, Ghizzoni M, Dekker FJ, Piwocka K.

Apoptosis. 2012 Sep;17(9):950-63. doi: 10.1007/s10495-012-0739-9.

PMID:
22696202
33.

Resveratrol delays replicative senescence of human mesothelial cells via mobilization of antioxidative and DNA repair mechanisms.

Mikuła-Pietrasik J, Kuczmarska A, Rubiś B, Filas V, Murias M, Zieliński P, Piwocka K, Książek K.

Free Radic Biol Med. 2012 Jun 1-15;52(11-12):2234-45. doi: 10.1016/j.freeradbiomed.2012.03.014. Epub 2012 Apr 30.

PMID:
22579575
34.

Role of annexin A6 isoforms in catecholamine secretion by PC12 cells: distinct influence on calcium response.

Podszywalow-Bartnicka P, Kosiorek M, Piwocka K, Sikora E, Zablocki K, Pikula S.

J Cell Biochem. 2010 Sep 1;111(1):168-78. doi: 10.1002/jcb.22685.

PMID:
20506562
35.

Expression of oncogenic kinase Bcr-Abl impairs mitotic checkpoint and promotes aberrant divisions and resistance to microtubule-targeting agents.

Wolanin K, Magalska A, Kusio-Kobialka M, Podszywalow-Bartnicka P, Vejda S, McKenna SL, Mosieniak G, Sikora E, Piwocka K.

Mol Cancer Ther. 2010 May;9(5):1328-38. doi: 10.1158/1535-7163.MCT-09-0936. Epub 2010 May 4.

36.

Ciprofloxacin inhibits proliferation and promotes generation of aneuploidy in Jurkat cells.

Koziel R, Szczepanowska J, Magalska A, Piwocka K, Duszynski J, Zablocki K.

J Physiol Pharmacol. 2010 Apr;61(2):233-9.

37.

The promise of slow down ageing may come from curcumin.

Sikora E, Bielak-Zmijewska A, Mosieniak G, Piwocka K.

Curr Pharm Des. 2010;16(7):884-92. Review.

PMID:
20388102
38.

Curcumin induces apoptosis-independent death in oesophageal cancer cells.

O'Sullivan-Coyne G, O'Sullivan GC, O'Donovan TR, Piwocka K, McKenna SL.

Br J Cancer. 2009 Nov 3;101(9):1585-95. doi: 10.1038/sj.bjc.6605308. Epub 2009 Oct 6.

39.

Induction of senescence with doxorubicin leads to increased genomic instability of HCT116 cells.

Sliwinska MA, Mosieniak G, Wolanin K, Babik A, Piwocka K, Magalska A, Szczepanowska J, Fronk J, Sikora E.

Mech Ageing Dev. 2009 Jan-Feb;130(1-2):24-32. doi: 10.1016/j.mad.2008.04.011. Epub 2008 May 1.

PMID:
18538372
40.

[Role of survivin in mitosis].

Wolanin K, Piwocka K.

Postepy Biochem. 2007;53(1):10-8. Review. Polish.

PMID:
17718383
41.

Curcumin induces cell death without oligonucleosomal DNA fragmentation in quiescent and proliferating human CD8+ cells.

Magalska A, Brzezinska A, Bielak-Zmijewska A, Piwocka K, Mosieniak G, Sikora E.

Acta Biochim Pol. 2006;53(3):531-8. Epub 2006 Sep 2.

42.

Curcumin abolishes apoptosis resistance of calcitriol-differentiated HL-60 cells.

Mosieniak G, Sliwinska M, Piwocka K, Sikora E.

FEBS Lett. 2006 Aug 21;580(19):4653-60. Epub 2006 Jul 21.

43.

Curcumin affects components of the chromosomal passenger complex and induces mitotic catastrophe in apoptosis-resistant Bcr-Abl-expressing cells.

Wolanin K, Magalska A, Mosieniak G, Klinger R, McKenna S, Vejda S, Sikora E, Piwocka K.

Mol Cancer Res. 2006 Jul;4(7):457-69.

44.

Curcumin induces caspase-3-dependent apoptotic pathway but inhibits DNA fragmentation factor 40/caspase-activated DNase endonuclease in human Jurkat cells.

Sikora E, Bielak-Zmijewska A, Magalska A, Piwocka K, Mosieniak G, Kalinowska M, Widlak P, Cymerman IA, Bujnicki JM.

Mol Cancer Ther. 2006 Apr;5(4):927-34.

45.

Bcr-Abl reduces endoplasmic reticulum releasable calcium levels by a Bcl-2-independent mechanism and inhibits calcium-dependent apoptotic signaling.

Piwocka K, Vejda S, Cotter TG, O'Sullivan GC, McKenna SL.

Blood. 2006 May 15;107(10):4003-10. Epub 2006 Feb 9.

PMID:
16469868
46.

Early loss of proliferative potential of human peritoneal mesothelial cells in culture: the role of p16INK4a-mediated premature senescence.

Ksiazek K, Piwocka K, Brzezińska A, Sikora E, Zabel M, Breborowicz A, Jörres A, Witowski J.

J Appl Physiol (1985). 2006 Mar;100(3):988-95. Epub 2005 Oct 27.

47.

Autocrine secretion of osteopontin results in degradation of I kappa B in Bcr-Abl-expressing cells.

Vejda S, Piwocka K, McKenna SL, Cotter TG.

Br J Haematol. 2005 Mar;128(5):711-21.

PMID:
15725094
48.

P-glycoprotein expression does not change the apoptotic pathway induced by curcumin in HL-60 cells.

Bielak-Mijewska A, Piwocka K, Magalska A, Sikora E.

Cancer Chemother Pharmacol. 2004 Feb;53(2):179-85. Epub 2003 Oct 3.

PMID:
14530869
49.

Curcumin induces caspase-3-independent apoptosis in human multidrug-resistant cells.

Piwocka K, Bielak-Mijewska A, Sikora E.

Ann N Y Acad Sci. 2002 Nov;973:250-4.

PMID:
12485871
50.

Effect of glutathione depletion on caspase-3 independent apoptosis pathway induced by curcumin in Jurkat cells.

Piwocka K, Jaruga E, Skierski J, Gradzka I, Sikora E.

Free Radic Biol Med. 2001 Sep 1;31(5):670-8.

PMID:
11522452

Supplemental Content

Loading ...
Support Center